Correction: HDAC7 is an actionable driver of therapeutic antibody resistance by macrophages from CLL patients
Crossref DOI link: https://doi.org/10.1038/s41388-020-01619-y
Published Online: 2020-12-22
Published Print: 2021-02-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Burgess, M.
Chen, Y. C. E.
Mapp, S.
Blumenthal, A.
Mollee, P.
Gill, D.
Saunders, N. A. http://orcid.org/0000-0002-2478-3420
Text and Data Mining valid from 2020-12-22
Version of Record valid from 2020-12-22
Article History
First Online: 22 December 2020
Free to read: This content has been made available to all.